DEFA14A 1 indiaglob20201221_defa14a.htm FORM DEFA14A indiaglob20201221_defa14a.htm



Washington, D.C.  20549 






Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐


Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12



India Globalization Capital, Inc.

(Exact name of registrant as specified in its charter) 



(Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check the appropriate box):



No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.



Title of each class of securities to which the transaction applies:


Aggregate number of securities to which the transaction applies:


Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):


Proposed maximum aggregate value of the transaction:


Total fee paid:


Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.



Amount Previously Paid:


Form, Schedule or Registration Statement No.:


Filing Party:


Date Filed:





 Supplement to Proxy Statement

India Globalization Capital Inc.

10224 Falls Road, Potomac,

Maryland, 20854


This filing supplements the definitive proxy statement on Schedule 14A filed by India Globalization Capital Inc. (the “Company”) with the Securities and Exchange Commission on December 8, 2020 (the “Proxy Statement”) by including the below press release to reiterate that John E. Lynch has been nominated as a Class A independent director for election at the Company’s 2020 Annual Meeting of Stockholders, to be held on January 11, 2021, replacing Class A director Sudhakar Shenoy.  




 India Globalization Capital Nominates Mr. John E. Lynch to its Board of Directors


BETHESDA, MD--(Businesswire –December 22, 2020) - India Globalization Capital, Inc. (NYSE MKT: IGC), today announced that John E. Lynch has been nominated as a Class A independent director for election at the Company’s 2020 Annual Meeting of Stockholders, to be held on January 11, 2021, replacing Class A director Sudhakar Shenoy.  


Mr. Lynch is an intellectual property attorney, admitted to practice before the Supreme Court of the United States, the United States Court of Appeals for the Second Circuit, and the United States Court of Appeals for the Federal Circuit, among other courts. He is a former partner of the law firm Fulbright & Jaworski L.L.P. 


Mr. Lynch helped negotiate the licensing of the patent filed by the University of South Florida titled “Extreme Low Dose THC as a Therapeutic and Prophylactic Agent for Alzheimer’s Disease”, which is the basis for our Drops of ClarityTM product HyalolexTM, available only in Puerto Rico, as well as the IGC-AD1 formulation, subject of a Phase 1 trial for which we are currently enrolling patients.


Mr. Lynch has been an independent consultant since 2003, and, for the past five years, he has served IGC as an Advisor. Mr. Lynch has been instrumental in developing the intellectual property strategy for the Company. Thanks to Mr. Lynch’s strategy and support, the Company has filed eleven patents with the United States Patent & Trademark Office (USPTO) including formulations for Cannabidiol-based compositions and methods for treating pain, cachexia and eating disorders, seizures, CNS disorders, restoring energy, stuttering and Tourette syndrome (TS), and Alzheimer’s disease related symptoms.


Mr. Lynch was an adjunct professor of law at Georgetown University Law Center, as well as an adjunct professor in Intellectual Property (IP) Law at the University of San Francisco School of Law. Mr. Lynch received a B.S., Chemistry, in 1960 from Fordham College and a J.D. in 1963 from Georgetown University Law Center.


We thank Mr. Shenoy for his guidance over the past fourteen years, and, while he will no longer be a director on the board, we will continue to seek his valuable advice.



Claudia Grimaldi





This material is first being released to stockholders on or about December 22, 2020 and should be read together with the Proxy Statement.





The Proxy Statement (including this amendment) and Fiscal 2020 Annual Report to Stockholders are available at and at the SEC website.